Medicine

siRNA treatment lowers triglycerides in patients with rare ailment

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran minimized triglyceride levels through 80% and also decreased the danger of pancreatitis in people along with persistent chylomicronemia, with or without a genetic medical diagnosis.

Articles You Can Be Interested In